Of @ patients in whom telaprevir-resistant variants were detected by PS at the time of treatment failure but not at the end of the study , DS revealed the presence of variants ( V@A/L/M , T@S , or R@K in @ % -@ % of the viral population ) in @ patients ( @ % ) at the end of the study .